A Randomized Phase III Non-inferiority Study of Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Phase of Trial: Phase III
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Nedaplatin (Primary) ; Cisplatin
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 17 Oct 2016 Status changed from recruiting to completed.
- 03 Sep 2013 Planned number of patients changed from 256 to 372 as reported by ClinicalTrials.gov record.
- 07 Mar 2012 Planned number of patients changed to 256.